These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27338109)

  • 1. Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy.
    Gonçalves NP; Martins D; Saraiva MJ
    Am J Pathol; 2016 Jul; 186(7):1913-24. PubMed ID: 27338109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glial cells in familial amyloidotic polyneuropathy.
    Gonçalves NP; Costelha S; Saraiva MJ
    Acta Neuropathol Commun; 2014 Dec; 2():177. PubMed ID: 25519307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.
    Martins D; Moreira J; Gonçalves NP; Saraiva MJ
    Dis Model Mech; 2017 Oct; 10(10):1253-1260. PubMed ID: 28993312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    J Neuropathol Exp Neurol; 2015 Mar; 74(3):203-17. PubMed ID: 25668561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
    Misumi Y; Ueda M; Obayashi K; Jono H; Su Y; Yamashita T; Ohshima T; Ando Y; Uchino M
    Hum Pathol; 2012 Jan; 43(1):96-104. PubMed ID: 21777941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
    Magalhães J; Saraiva MJ
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1097-106. PubMed ID: 22082661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inflammatory response to sciatic nerve injury in a familial amyloidotic polyneuropathy mouse model.
    Gonçalves NP; Teixeira-Coelho M; Saraiva MJ
    Exp Neurol; 2014 Jul; 257():76-87. PubMed ID: 24800914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the heat shock response in familial amyloidotic polyneuropathy.
    Santos SD; Magalhães J; Saraiva MJ
    J Neuropathol Exp Neurol; 2008 May; 67(5):449-55. PubMed ID: 18431252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy.
    Santos SD; Cardoso I; Magalhães J; Saraiva MJ
    J Pathol; 2007 Oct; 213(2):200-9. PubMed ID: 17724793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of ERK1/2 MAP kinases in familial amyloidotic polyneuropathy.
    Monteiro FA; Sousa MM; Cardoso I; do Amaral JB; Guimarães A; Saraiva MJ
    J Neurochem; 2006 Apr; 97(1):151-61. PubMed ID: 16515552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy.
    Macedo B; Batista AR; Ferreira N; Almeida MR; Saraiva MJ
    Biochim Biophys Acta; 2008 Sep; 1782(9):517-22. PubMed ID: 18572024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
    Hoepfner J; Kleinsorge M; Papp O; Alfken S; Heiringhoff R; Pich A; Sauer V; Zibert A; Göhring G; Schmidt H; Sgodda M; Cantz T
    Biol Chem; 2017 Jul; 398(8):939-954. PubMed ID: 28051995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular consequences of transthyretin deposition.
    Saraiva MJ
    Amyloid; 2003 Aug; 10 Suppl 1():13-6. PubMed ID: 14640036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. αB-crystallin (HspB5) in familial amyloidotic polyneuropathy.
    Magalhães J; Santos SD; Saraiva MJ
    Int J Exp Pathol; 2010 Dec; 91(6):515-21. PubMed ID: 20804537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody therapy for familial amyloidotic polyneuropathy.
    Su Y; Jono H; Torikai M; Hosoi A; Soejima K; Guo J; Tasaki M; Misumi Y; Ueda M; Shinriki S; Shono M; Obayashi K; Nakashima T; Sugawara K; Ando Y
    Amyloid; 2012 Jun; 19 Suppl 1():45-6. PubMed ID: 22506915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
    Cardoso I; Saraiva MJ
    FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial amyloidotic polyneuropathy and transthyretin.
    Nagasaka T
    Subcell Biochem; 2012; 65():565-607. PubMed ID: 23225017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.